Clinical Pharmacological Approach To The Treatment Of Eclampsia In Pregnant Women With Antihypertensive Drugs

Authors

  • Usmonova F.T. Assistant of the Department of pharmacology, clinical pharmacology and medical biotechnology ASMI

DOI:

https://doi.org/10.62480/tjms.2025.vol42.pp42-44

Keywords:

hypertensive gestational disorders, preeclampsia, complications of preeclampsia.

Abstract

The review considers the possibilities of predicting preeclampsia (PE) and its complications, modern criteria for diagnosing hypertensive gestational disorders, as well as the tactics of their intensive therapy. Particular attention is paid to providing anesthetic support during operative delivery in patients with PE and its complications

References

Mol B.W.J., Roberts C.T., Thangaratinam S., et al. Pre-eclampsia. Lancet. 2016; 5(387): 999–1011.

DOI: 10.1016/S0140-6736(15)00070-7

Say L., Chou D., Gemmill A., et al. Global causes of maternal death: a WHO systematic analysis.

The Lancet Global Health. 2014; 2(6): 323–333.

Maternal mortality in the Russian Federation in 2014. Methodological letter of the Ministry of

Health of the Russian Federation dated 09.10.2015.

Bokslag A., van Weissenbruch M., Mol B.W., et al. Preeclampsia; short and long-term consequences

for mother and neonate. Early Hum Dev. 2016; 102:47–50. DOI: 10.1016/j.earlhumdev.2016.09.007

Cífková R., Johnson M.R., Kahan T., et al. Peripartum management of hypertension. A position

paper of the ESC Council on Hypertension and the European Society of Hypertension. Eur Heart J

Cardiovasc Pharmacother. 2019; 16; pvz82. DOI: 10.1093/ehjcvp/pvz082

Downloads

Published

2025-03-13

Issue

Section

Articles

How to Cite

Clinical Pharmacological Approach To The Treatment Of Eclampsia In Pregnant Women With Antihypertensive Drugs. (2025). Texas Journal of Medical Science, 42, 42-44. https://doi.org/10.62480/tjms.2025.vol42.pp42-44